The announcement came too late to boost Shanghai shares, but Hong Kong jumped in the final hour of trading, with the Hang Seng closing up 2.8%.
Sibanye said it will also receive royalties of up to USD5 per pound on all uranium sold. Sibanye placed the Beatrix 4 shaft on 'care and maintenance' in 2023 "primarily due to declining gold reserves ...
"ISS states that Frasers has offered a superficial view of performance and no specific plans for change and the two Frasers candidates, Mike Ashley and Mike Lennon, have real conflicts of interest, ...
For the year ended June 30 the oil and gas company, which is focused on developing the Ahpun and Kodiak onshore oil fields in Alaska, said its pretax loss widened significantly to USD13.4 million from ...
Downing Street said the economy was Starmer's "number one priority" but insisted he would still be able to raise concerns about the Saudi government's human rights record.
(Alliance News) - Tavistock Investments PLC on Monday said it made "significant" progress with its strategic refocussing as it proposed a higher dividend despite turning to an interim loss.
(Alliance News) - BP PLC on Monday announced it is teaming up with Tokyo-based JERA Co Inc to combine their offshore wind businesses to form a new joint venture.
(Alliance News) - Synectics PLC on Monday said it expects full-year profit to be "materially ahead of expectations" due to continued momentum in the second half.
(Alliance News) - Woodbois Ltd on Monday said key international clients had placed total orders valued at around USD4.5 million. The Guernsey-based timber trader said its major clients in Libya, Iraq ...
"The UK will immediately suspend all programme support to the Georgian government, restrict defence cooperation, and limit engagement" with the authorities, Lammy added. Thousands have taken part in ...
"The breakthrough therapy designation granted by the FDA underscores the significant unmet need for new treatments for patients with previously treated EGFR-mutated non-small cell lung cancer who have ...
In addition, GSK said its Blenrep drug has been approved for priority review in China to treat sufferers of myeloma, a bone marrow cancer. The regulatory submission is supported by phase III ...